Clinical Challenges

Second Malignancies in Chronic Lymphocytic Leukemia

Erin Streu

late effects, leukemia, lymphoma, hematology, ambulatory care, clinical practice
ONF 2013, 41(1), 95-98. DOI: 10.1188/14.ONF.95-98

A 73-year-old patient named Mr. G was diagnosed with Rai stage 0 chronic lymphocytic leukemia (CLL) in 2007. The diagnosis was made incidentally by a routine complete blood count that reported lymphocytosis, and the diagnosis was confirmed by flow cytometry. His family history for cancer only included a sister previously diagnosed with melanoma. Because of his early stage, he was followed in clinic and remained asymptomatic for three years. He then presented with supraclavicular and bilateral axillary lymphadenopathy measuring 4-6 cm, a rising white blood cell count of 43,620 u/L, and hemoglobin and platelet count slightly less than normal (12 g/dl and 136,000 u/L, respectively). Mr. G was started on chlorambucil and, after two months of treatment, was held because of a generalized papular erythematous rash covering 40% of his back, chest, and arms. He was referred to dermatology for assessment, and biopsy confirmed the rash as leukemic infiltration of the skin. A second biopsy performed on a 2 cm lesion found incidentally behind his right ear was positive for basal cell carcinoma (BCC).

Jump to a section

    References

    Albregts, T., Orengo, I., Salasche, S., Duncan, L., Sillman, J., & Hassoun, H. (1998). Squamous cell carcinoma in a patient with chronic lymphocytic leukemia: An intraoperative diagnostic challenge for the Mohs surgeon. Dermatologic Surgery, 24, 269-272. doi:10.1111/J.1524-4725.1998.tb04141.x
    Beiggi, S., Lambert, P.J., Pitz, M., Seftel, M.D., & Johnston, J.B. (2012). Risk of second malignancies in patients with chronic lymphocytic leukemia: A population-based Canadian study [Abstract 5505]. Cancer Research, 72(8, Suppl. 1). Retrieved from http://bit.ly/1crhZnL http://bit.ly/1crhZnL
    Champion, V.L., & Rawl, S.M. (2005). Secondary prevention of cancer. Seminars in Oncology Nursing, 21, 252-259.
    Vargo, N. (2003). Basal cell and squamous cell carcinoma. Seminars in Oncology Nursing, 19, 12-21.
    Albregts, T., Orengo, I., Salasche, S., Duncan, L., Sillman, J., & Hassoun, H. (1998). Squamous cell carcinoma in a patient with chronic lymphocytic leukemia: An intraoperative diagnostic challenge for the Mohs surgeon. Dermatologic Surgery, 24, 269-272. doi:10.1111/J.1524-4725.1998.tb04141.x
    American Cancer Society. (2013). American Cancer Society guidelines for the early detection of cancer. Retrieved from http://www.cancer.org/healthy/findcancerearly/cancerscreeningguidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer
    American Society of Clinical Oncology. (2012). Cancer. Net: Cancer screening. Retrieved from http://www.cancer.net/all-about-cancer/risk-factors-and-prevention/cancer-screening
    Barrett, J., & Le Blanc, K. (2009). Cancer chemotherapy and immune regulation. American Journal of Immunology, 5, 8-16. doi:10.1172/JCI31405
    Beiggi, S., Lambert, P.J., Pitz, M., Seftel, M.D., & Johnston, J.B. (2012). Risk of second malignancies in patients with chronic lymphocytic leukemia: A population-based Canadian study [Abstract 5505]. Cancer Research, 72(8, Suppl. 1). Retrieved from http://bit.ly/1crhZnL http://bit.ly/1crhZnL
    Champion, V.L., & Rawl, S.M. (2005). Secondary prevention of cancer. Seminars in Oncology Nursing, 21, 252-259.
    Dasanu, C.A., & Alexandrescu, D.T. (2007). Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia. Medscape General Medicine, 9(4), 35-48.
    Frierson, H., Deutsch, B., & Levine, P. (1988). Clinicopathological features of cutaneous squamous cell carcinomas of the head and neck in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Human Pathology, 19, 1397-1402.
    Hartley, B., Searle, A., Breach, N., Rhys-Evans, P., & Henk, J. (1996). Aggressive cutaneous squamous cell carcinoma of the head and neck in patients with chronic lymphocytic leukaemia. Journal of Laryngology and Otology, 110, 694-695.
    Jain, P., & O'Brien, S. (2012). Richter's transformation in chronic lymphocytic leukemia. Oncology, 26, 1146-1152. doi:10.1186/1478-811X-10-43
    Levi, F., Randimbison, L., Te, V.C., & La Vecchia, C. (1996). Non-Hodgkin lymphomas, chronic lymphocytic leukemias, and skin cancers. British Journal of Cancer, 74, 1847-1850.
    Mehrany, K., Weenig, R., Pittelkow, M., Roenigk, R., & Otley, C. (2004). High recurrence rates of basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia. Archives of Dermatological Research, 140, 985-988. doi:10.1001/archderm.140.8.985
    Molica, S. (2005). Second neoplasms in chronic lymphocytic leukemia: Incidence and pathogenesis with emphasis on the role of different therapies. Leukemia and Lymphoma, 46, 49-54. doi:10.1080/10428190400007524
    Moran, M., Browning, M., & Buckby, E. (2007). Nursing guidelines for managing infections in patients with chronic lymphocytic leukemia. Clinical Journal of Oncology Nursing, 11, 914-924. doi:10.1188/07.CJON.914-924
    National Cancer Institute. (n.d.). Screening and testing to detect cancer. Retrieved from http://www.cancer.gov/cancertopics/screening
    Robak, E., & Robak, T. (2007). Skin lesions in chronic lymphocytic leukemia. Leukemia and Lymphoma, 48, 855-865. doi:10.1016/j.jaad.2008.08.047
    Royle, J.A., Baade, P.D., Joske, D., Girshik, J., & Fritischi, L. (2011). Second cancer incidence and cancer mortality among chronic lymphocytic leukemia patients: A population-based study. British Journal of Cancer, 105, 1076-1081. doi:10.1038/bjc.2011.313
    Tsimberidou, A.M., Wen, S., McLaughlin, P., O'Brien, S., Wierda, W.G., Lerner, S., … Keating, M. (2009). Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. Journal of Clinical Oncology, 27, 904-910. doi:10.1200/JCO.2008.17.5398.
    Vargo, N. (2003). Basal cell and squamous cell carcinoma. Seminars in Oncology Nursing, 19, 12-21.
    Wadhwa, P.D., & Morrison, V.A. (2006). Infectious complications of chronic lymphocytic leukemia. Seminars in Oncology Nursing, 33, 240-249.
    Wierda, W.G., O'Brien, S., Wang, X., Faderl, S., Ferrajoli, A., Do, K.A., … Keating, M. (2009). Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment. Journal of Clinical Oncology, 27, 1637-1643. doi:10.1200/JCO.208.18.1701
    Wiernik, P.H. (2004). Second neoplasms in patients with chronic lymphocytic leukemia. Current Treatment Options in Oncology, 5, 215-223.
    World Health Organization. (2013). Sun protection. Retrieved from http://www.who.int/uv/sun_protection/en
    Yoon, J.Y., Lafarge, S., Dawe, D., Lakhi, S., Kumar, R., Morales, C., … Johnston, J.B. (2012). Association of interleukin-6 and interleukin-8 with poor prognosis in elderly patients with chronic lymphocytic leukemia. Leukemia and Lymphoma, 53, 1735-1742.